As of 2026-04-10, the Relative Valuation of Pfizer Inc (PFE) is 25.96 USD. This relative valuation is based on P/E multiples. With the latest stock price at 27.22 USD, the upside of Pfizer Inc based on Relative Valuation is -4.6%.
The range of the Relative Valuation is 22.54 - 32.70 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.2x - 23.9x | 19.4x |
| Forward P/E multiples | 16.9x - 20.6x | 19.1x |
| Fair Price | 22.54 - 32.70 | 25.96 |
| Upside | -17.2% - 20.2% | -4.6% |
| Date | P/E |
| 2026-04-09 | 19.92 |
| 2026-04-08 | 20.11 |
| 2026-04-07 | 19.84 |
| 2026-04-06 | 20.37 |
| 2026-04-02 | 20.73 |
| 2026-04-01 | 20.90 |
| 2026-03-31 | 20.55 |
| 2026-03-30 | 20.33 |
| 2026-03-27 | 19.79 |
| 2026-03-26 | 20.18 |
| 2026-03-25 | 19.97 |
| 2026-03-24 | 19.73 |
| 2026-03-23 | 19.60 |
| 2026-03-20 | 19.74 |
| 2026-03-19 | 20.06 |
| 2026-03-18 | 20.00 |
| 2026-03-17 | 20.09 |
| 2026-03-16 | 19.48 |
| 2026-03-13 | 19.46 |
| 2026-03-12 | 19.66 |
| 2026-03-11 | 19.98 |
| 2026-03-10 | 19.88 |
| 2026-03-09 | 19.62 |
| 2026-03-06 | 19.80 |
| 2026-03-05 | 19.48 |
| 2026-03-04 | 19.49 |
| 2026-03-03 | 19.46 |
| 2026-03-02 | 19.95 |
| 2026-02-27 | 20.24 |
| 2026-02-26 | 19.84 |
| 2026-02-25 | 19.83 |
| 2026-02-24 | 19.87 |
| 2026-02-23 | 19.81 |
| 2026-02-20 | 19.51 |
| 2026-02-19 | 19.66 |
| 2026-02-18 | 20.03 |
| 2026-02-17 | 20.03 |
| 2026-02-13 | 20.19 |
| 2026-02-12 | 20.11 |
| 2026-02-11 | 20.30 |
| 2026-02-10 | 20.21 |
| 2026-02-09 | 19.80 |
| 2026-02-06 | 19.92 |
| 2026-02-05 | 19.39 |
| 2026-02-04 | 19.60 |
| 2026-02-03 | 18.86 |
| 2026-02-02 | 19.52 |
| 2026-01-30 | 19.35 |
| 2026-01-29 | 19.11 |
| 2026-01-28 | 18.93 |